Cargando…
PKC-ζ mediated reduction of the extracellular vesicles-associated TGF-β1 overcomes radiotherapy resistance in breast cancer
BACKGROUND: Radiotherapy is widely applied in breast cancer treatment, while radiotherapy resistance is inevitable. TGF-β1 has been considered to be an endogenous factor for the development of radiotherapy resistance. As a large portion of TGF-β1 is secreted in an extracellular vesicles-associated f...
Autores principales: | Zhang, Fayun, Zheng, Zifeng, Wang, Luoyang, Zeng, Wenfeng, Wei, Wenjing, Zhang, Chunling, Zhao, Ziran, Liang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082517/ https://www.ncbi.nlm.nih.gov/pubmed/37029374 http://dx.doi.org/10.1186/s13058-023-01641-4 |
Ejemplares similares
-
Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation
por: Zhang, Fayun, et al.
Publicado: (2016) -
Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity
por: Zhang, Fayun, et al.
Publicado: (2021) -
PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction
por: Yin, Xiaozhe, et al.
Publicado: (2020) -
O-GlcNAc on PKCζ Inhibits the FGF4-PKCζ-MEK-ERK1/2 Pathway via Inhibition of PKCζ Phosphorylation in Mouse Embryonic Stem Cells
por: Miura, Taichi, et al.
Publicado: (2017) -
Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-β-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer Cells
por: Lou, Changjie, et al.
Publicado: (2012)